Squarepoint’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,401
| Closed | -$409K | – | 3842 |
|
|
2021
Q4 | $409K | Buy |
+4,401
| New | +$290K | ﹤0.01% | 2276 |
|
|
2021
Q3 | – | Sell |
-22,429
| Closed | -$1.53M | – | 3708 |
|
|
2021
Q2 | $1.53M | Buy |
22,429
+16,104
| +255% | +$1.05M | 0.01% | 1341 |
|
|
2021
Q1 | $439K | Buy |
+6,325
| New | +$487K | ﹤0.01% | 2116 |
|
|
2020
Q3 | – | Sell |
-17,222
| Closed | -$1.08M | – | 2977 |
|
|
2020
Q2 | $1.08M | Buy |
+17,222
| New | +$948K | 0.02% | 900 |
|
|
2020
Q1 | – | Sell |
-16,005
| Closed | -$727K | – | 2761 |
|
|
2019
Q4 | $727K | Buy |
16,005
+244
| +2% | +$11.5K | ﹤0.01% | 1538 |
|
|
2019
Q3 | $721K | Sell |
15,761
-29,385
| -65% | -$1.65M | 0.01% | 1429 |
|
|
2019
Q2 | $2.65M | Buy |
45,146
+25,339
| +128% | +$1.31M | 0.03% | 702 |
|
|
2019
Q1 | $888K | Buy |
19,807
+6,993
| +55% | +$321K | 0.01% | 1167 |
|
|
2018
Q4 | $499K | Sell |
12,814
-30,802
| -71% | -$1.21M | 0.01% | 1246 |
|
|
2018
Q3 | $2.01M | Buy |
43,616
+38,216
| +708% | +$1.55M | 0.02% | 731 |
|
|
2018
Q2 | $235K | Buy |
+5,400
| New | +$232K | ﹤0.01% | 1482 |
|
|
2018
Q1 | – | Sell |
-15,135
| Closed | -$514K | – | 2314 |
|
|
2017
Q4 | $514K | Buy |
+15,135
| New | +$431K | 0.01% | 1196 |
|
|
2017
Q2 | – | Sell |
-5,223
| Closed | -$76K | – | 1905 |
|
|
2017
Q1 | $76K | Sell |
5,223
-139
| -3% | -$2.06K | ﹤0.01% | 1435 |
|
|
2016
Q4 | $76K | Buy |
+5,362
| New | +$83.1K | ﹤0.01% | 1662 |
|
|
2016
Q3 | – | Sell |
-3,040
| Closed | -$52K | – | 1345 |
|
|
2016
Q2 | $52K | Buy |
+3,040
| New | +$54.3K | ﹤0.01% | 1025 |
|
|
2016
Q1 | – | Sell |
-12,620
| Closed | -$240K | – | 1536 |
|
|
2015
Q4 | $240K | Buy |
+12,620
| New | +$257K | 0.03% | 901 |
|
Squarepoint's ARNA Position: Q1 2022 in Review
Squarepoint sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 4,401 shares — an estimated $409K sold.
Squarepoint first reported a position in ARNA in Q4 2015 and held it in 16 quarters. The position peaked at $2.65M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Squarepoint reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Squarepoint sold 4,401 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $409K.
- Squarepoint first reported a position in Arena Pharmaceuticals Inc in Q4 2015 and held it in 16 quarters.
- Squarepoint's Arena Pharmaceuticals Inc position peaked at $2.65M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Squarepoint's 13F filing for Q1 2022, filed 16 May 2022.